ADRA2C

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, ADRA2C mutation is significantly associated with the RNA expression of many other genes, with 524 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible ADRA2C-associated genes across cancer lineages are RN7SKP162, RNA5SP84, and RN7SKP59. Each is linked with ADRA2C in more than 2 cancer types. Because this analysis shows association rather than direction, both ADRA2C-to-partner and partner-to-ADRA2C results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ADRA2C→partner) and Y-score (partner→ADRA2C) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
HNSCRN7SKP162 →+0.126+5.357<.001.00133
HNSCRNA5SP84 →+0.224+4.608<.001.00532
UCECRN7SKP59 →+0.070+2.835.007.00332
STADEEF1E1-BLOC1S5 →+0.040+5.026.006.00932
UCECHNMT →-0.757-3.568.004.00231
UCECCCDC3 →-0.817-2.807.009.00331
Each partner links to its Q-omics profile. Showing the 6 strongest of 524 associations by consensus.

Exploration